AgomAb Therapeutics NV (AGMB)

NASDAQ: AGMB · Real-Time Price · USD

14.85

-0.15 (-1.00%)

At close: Aug 11, 2026, 4:00 PM EDT

14.85

0.00 (0.00%)

After-hours: Aug 11, 2026, 4:10 PM EDT

AgomAb Therapeutics NV Financials Overview

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Operating Income	-65.94	-59.28	-48.02	-31.19
Net Income	-66.65	-62.55	-46.27	-11.39
Earnings Per Share	-80.16	-143.22	-107.09	-35.63
EPS Growth	-	-	-	-

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Cash & Investments	251.98	116.51	171.46
Total Debt	1.14	1.25	1.55
Net Cash (Debt)	250.84	115.26	169.91
Net Cash Growth	47.63%	-32.17%	-
Net Cash Per Share	12.15	213.00	314.00

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Operating Cash Flow	-56.73	-51.74	-46.83	-24.59
Capital Expenditures	-	-0	-0.68	-
Free Cash Flow	-56.73	-51.75	-47.5	-24.59
Free Cash Flow Growth	-	-	-	-